These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6174578)

  • 21. A review of Providencia bacteremia in a general hospital, with a comment on patterns of antimicrobial sensitivity and use.
    Prentice B; Robinson BL
    Can Med Assoc J; 1979 Sep; 121(6):745-9. PubMed ID: 519613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isolation of seven distinct carbapenemase-producing Gram-negative organisms from a single patient.
    Creighton J; Heffernan H; Howard J
    J Antimicrob Chemother; 2017 Jan; 72(1):317-319. PubMed ID: 27621176
    [No Abstract]   [Full Text] [Related]  

  • 23. Comparative in vitro activities of 13 antimicrobial agents against Morganella-Proteus-Providencia group bacteria from urinary tract infections.
    Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Ravagnan G
    Antimicrob Agents Chemother; 1987 Oct; 31(10):1644-7. PubMed ID: 3435110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Commercial identification systems often fail to identify Providencia stuartii.
    Cornaglia G; Dainelli B; Berlutti F; Thaller MC
    J Clin Microbiol; 1988 Feb; 26(2):323-7. PubMed ID: 3277997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective survey of fecal, urinary tract, and environmental colonization by Providencia stuartii in two geriatric wards.
    Hawkey PM; Penner JL; Potten MR; Stephens M; Barton LJ; Speller DC
    J Clin Microbiol; 1982 Sep; 16(3):422-6. PubMed ID: 7130358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of endemic Providencia stuartii isolates from patients with urinary devices.
    Hollick GE; Nolte FS; Calnan BJ; Penner JL; Barton LJ; Spellacy A
    Eur J Clin Microbiol; 1984 Dec; 3(6):521-5. PubMed ID: 6526019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. O serotyping of Providencia stuartii isolates collected from twelve hospitals.
    Penner JL; Hinton NA; Duncan IB; Hennessy JN; Whiteley GR
    J Clin Microbiol; 1979 Jan; 9(1):11-4. PubMed ID: 429535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uropathogenicity in rats and mice of Providencia stuartii from long-term catheterized patients.
    Johnson DE; Lockatell CV; Hall-Craigs M; Mobley HL; Warren JW
    J Urol; 1987 Sep; 138(3):632-5. PubMed ID: 3625871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Providencia stuartii.
    R I Med J; 1973 Oct; 56(10):427-8. PubMed ID: 4518224
    [No Abstract]   [Full Text] [Related]  

  • 30. Nosocomially acquired bacteriuria due to Proteus rettgeri and Providencia stuartii.
    Washington JA; Senjem DH; Haldorson A; Schutt AH; Martin WJ
    Am J Clin Pathol; 1973 Dec; 60(6):836-8. PubMed ID: 4758277
    [No Abstract]   [Full Text] [Related]  

  • 31. Numerical analysis of electrophoretic protein patterns of Providencia stuartii strains from urine, wound and other clinical sources.
    Costas M; Holmes B; Wood AC
    J Appl Bacteriol; 1990 May; 68(5):505-18. PubMed ID: 2370236
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Urinary tract infections due to Proteus rettgeri].
    Bauernfeind A
    Fortschr Med; 1973 May; 91(13):588. PubMed ID: 4701128
    [No Abstract]   [Full Text] [Related]  

  • 33. Rare occurrence of Proteus vulgaris in faeces: a reason for its rare association with urinary tract infections.
    Senior BW; Leslie DL
    J Med Microbiol; 1986 Mar; 21(2):139-44. PubMed ID: 3512839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bacteraemia due to tribe Proteeae: a review of 132 cases during a decade (1991-2000).
    Kim BN; Kim NJ; Kim MN; Kim YS; Woo JH; Ryu J
    Scand J Infect Dis; 2003; 35(2):98-103. PubMed ID: 12693558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Infection caused by Proteus mirabilis strains with transferrable gentamicin-resistance factors.
    Datta N
    Lancet; 1975 Jun; 1(7921):1355-7. PubMed ID: 48945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidrug-resistant gram-negative bacterial infections in a teaching hospital in Ghana.
    Agyepong N; Govinden U; Owusu-Ofori A; Essack SY
    Antimicrob Resist Infect Control; 2018; 7():37. PubMed ID: 29541448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Bacterial flora and current problems of resistence in urinary tract infections (author's transl)].
    Peters HJ; Ludwig G; Ueberle W
    Med Klin; 1973 Sep; 68(39):1265-71. PubMed ID: 4201041
    [No Abstract]   [Full Text] [Related]  

  • 38. [The sensitivity to antibiotics of Proteus strains isolated from patients with urologic disorders].
    Teodorovici G; Zvorişteanu V; Ivan A; Antonescu M; Gheorghiţă Z; Stoica O
    Rev Med Chir Soc Med Nat Iasi; 1966; 70(3):701-8. PubMed ID: 5968110
    [No Abstract]   [Full Text] [Related]  

  • 39. Proteus infections in a general hospital. II. Some clinical and epidemiological characteristis. With an analysis of 71 cases of proteus bacteremia.
    Adler JL; Burke JP; Martin DF; Finland M
    Ann Intern Med; 1971 Oct; 75(4):531-6. PubMed ID: 5094068
    [No Abstract]   [Full Text] [Related]  

  • 40. Population-based laboratory surveillance for tribe Proteeae isolates in a large Canadian health region.
    Laupland KB; Parkins MD; Ross T; Pitout JD
    Clin Microbiol Infect; 2007 Jul; 13(7):683-8. PubMed ID: 17403132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.